IMRT SX1

Rx: 66Gy/30fx to PTV66, also PTV60 and PTV56 (simultaneous integrated boost)

RTOG 0920

2:31 IMRT treatment field delivery time

Beams
DVH
Simple DVH Metrics

Name (ID): UniLateral_HN, (UniLateral_HN)
Plan or PlanSum ID: 7fld1bSX1norm

Structure ID Structure Code Patient Structure DVH Objective Evaluator Variation Priority Met Achieved
PTV66   PTV_High 66 D95.0%[Gy] >=66 64   Goal 66.283 Gy
PTV66EVAL-08   PTV66Eval-08 Min[Gy] >=62 60   Goal 63.585 Gy
PTV60   PTV_Int 60 D95.0%[Gy] >=64 60   Variation 60.764 Gy
PTV60 (GREATER THAN 8MM FROM SKIN)   PTV60 Eval-08 Min[Gy] >=60 56   Not met 55.937 Gy
PTV60   PTV_Int 60 Max[Gy] <70 72   Goal 68.150 Gy
PTV56   PTV_Low 54 D95.0%[Gy] >=56 54   Goal 56.478 Gy
PTV56EVAL-08   PTV56Eval-08 Min[Gy] >=52 50   Variation 50.013 Gy
SPINAL_CORD_PRV   SpinalCord_05 D0.03cc[Gy] <48 50   Goal 46.062 Gy
SPINAL_CORD_PRV   SpinalCord_05 D0.01cc[Gy] <50 52   Goal 46.527 Gy
BRAINSTEM_PRV   BRAINSTEM_PRV D0.03cc[Gy] <=52     Goal 50.992 Gy
LIPS   LIPS Mean[Gy] <20     Goal 14.717 Gy
LIPS (NON ORAL CAVITY CANCER)   LIPS Max[Gy] <50     Goal 30.039 Gy
ORAL CAVITY   ORALCAVITY Max[Gy] <60     Not met 67.919 Gy
ORAL CAVITY (NON ORAL CAVITY CANCER)   ORALCAVITY Mean[Gy] <50     Goal 47.692 Gy
RIGHT PAROTID   PAROTID_R Mean[Gy] <26     Goal 7.586 Gy
RIGHT PAROTID   PAROTID_R D50.0%[Gy] <30     Goal 6.500 Gy
TOTAL PAROTID   PAROTID_TOTAL_R D20.0cc[Gy] <20     Goal 0.000 Gy
OARPHARYNX   PharynxConstTtl D33.0%[Gy] <=50     Not met 56.171 Gy
OARPHARYNX   PharynxConstTtl Mean[Gy] <45     Goal 44.623 Gy
OARPHARYNX   PharynxConstTtl D15.0%[Gy] <=60     Goal 57.830 Gy
CERVICAL ESOPHAGUS   ESOPHAGUS_UPPER D33.0%[Gy] >=45 35   Variation 41.572 Gy
CERVICAL ESOPHAGUS   ESOPHAGUS_UPPER Mean[Gy] <35     Goal 33.124 Gy
CERVICAL ESOPHAGUS   ESOPHAGUS_UPPER D15.0%[Gy] <=54     Goal 53.987 Gy
GLOTTIC AND SUPRAGLOTTIC LARYNX   LARYNX Max[Gy] <45     Not met 58.575 Gy
MANDIBLE   MANDIBLE Max[Gy] <66     Not met 70.019 Gy
UNSPECIFIED TISSUE OUTSIDE TARGETS (WITH BOOST)   NS_NormalTissue D1.0%[Gy] <=72.6     Goal 56.684 Gy
UNSPECIFIED TISSUE OUTSIDE TARGETS   NS_NormalTissue D5.0%[Gy] <=66     Goal 39.777 Gy
UNSPECIFIED TISSUE OUTSIDE TARGETS   NS_NormalTissue D1.0cc[Gy] <=72.6     Goal 69.706 Gy
Technical Plan Comments

Unilateral head and neck treated SIB following RTOG 0920.  This seven (7) field IMRT plan was created with custom gantry positions to mimic the irregular volume target shape of the lowest dose target on the transverse planes.  Also, consideration was given to place beam edges so that a sharp gradient could be achieved against the highest value OARs (oral cavity, pharynx, larynx, and esophagus).  From a beam's eye view, unique collimator rotations were selected per field to match the general angle of the target volume.

The challenge was achieving the minimum PTV coverage constraint for targets that were overlapping or abutting OARs which could not be adequately spared due to the target size, location and overlap.  When a protocol enforces a minimum dose to the target, the temptation is to simply perform a uniform expansion on the target and optimize on the expanded target.  However, in this case, an optimization PTV was created and stretched outward only along the edges of the real PTV where the minimum dose was not met.  Careful attention was paid to minimize stretching where the target interfaced/overlapped with an OAR.

Physician Comments

This is clearly a more challenging case. The plan is overall adequate. Some remarkable dose gradients and dose falloffs are achieved. The problematic areas are in the overall zones with the oral cavity mostly, but also the larynx, pharynx and mandible. However, these are expected given the overlap with the PTV. If the PTV is corrected, then the overdose areas these OARs are clinically acceptable since the overlaps are very clear. This is a clinically acceptable plan.

Links

3rd party software plan report

PDF

           

DICOM patient export         

ZIP        

Any reference to a "plan study" are simply what the organizers call each case and may not be a "study" in the FDA sense as they may not have been published in a peer reviewed journal.
Varian does not provide medical advice and these are illustrative examples only.
Leading plans by expert planner. Your results may vary.

FOR EDUCATIONAL AND SCIENTIFIC EXCHANGE ONLY – NOT FOR SALES OR PROMOTIONAL USE.